MyAverix Finance MyAverix Finance

LSE

Novo Nordisk A/S (0TDD)

Novo Nordisk A/S (0TDD) is listed on LSE. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 0TDD

P/E ratio
18.00

Novo Nordisk A/S (0TDD) — FAQ

What is 0TDD's P/E ratio?

The price-to-earnings (P/E) ratio for Novo Nordisk A/S (0TDD) is 18.00 (data as of 2026-05-23).

Does Novo Nordisk A/S pay a dividend?

Dividend yield is not available in the current snapshot for Novo Nordisk A/S (0TDD). Check the MyAverix Finance app for the latest dividend data.

What exchange is 0TDD listed on?

0TDD is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play